Intranasal delivery of Adeno-Cre into LSL-Kras; p53FL/FL or LSL-Kras; Ink4a/ARFFL/FL mice led to the development of multiple, aggressive adenocarcinomas in the lungs bilaterally. Here, CDKN2A is linked to adenocarcinoma.